ProfileGDS5822 / ILMN_1239352
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 22% 36% 25% 8% 11% 20% 21% 50% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 113.522
GSM1276600PDAC Late Ablation Control 21936
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 112.325
GSM1276603PDAC Late Ablation 27.78
GSM1276604PDAC Late Ablation 38.511
GSM1303940PDAC Late Ablation_anti-CTLA4 112.920
GSM1303941PDAC Late Ablation_anti-CTLA4 21121
GSM1303942PDAC Late Ablation_anti-CTLA4 325.650